{
    "clinical_study": {
        "@rank": "114315", 
        "arm_group": {
            "arm_group_label": "Cohort"
        }, 
        "brief_summary": {
            "textblock": "This non-interventional, observational, open-label multi-center follow-up study of patients\n      from the U-Act-Early trial (ML22497) will evaluate the long-term efficacy and safety of\n      starting tight control treatment with RoActemra/Actemra (tocilizumab) and/or methotrexate in\n      patients early in the disease followed by treatment according to standard of care in routine\n      clinical practice in a three year follow-up, independently of what treatment the patient\n      will be receiving."
        }, 
        "brief_title": "U-Act-After: An Observational Study on Long-Term Efficacy of Tight Control RoActemra/Actemra (Tocilizumab) and/or Methotrexate in Patients With Early Rheumatoid Arthritis Who Have Participated in the U-Act-Early Study (ML22497)", 
        "completion_date": {
            "#text": "September 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Rheumatoid Arthritis", 
        "condition_browse": {
            "mesh_term": [
                "Arthritis", 
                "Arthritis, Rheumatoid"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients must have participated in the U-Act-Early trial (ML22497); these are adult\n             patients (> 20 years of age) with rheumatoid arthritis.\n\n          -  Patients must be willing to give written informed consent\n\n        Exclusion Criteria:\n\n          -  Patients who did not participate in the U-Act-Early trial\n\n          -  Patients who are drop-outs in the U-Act-Early trial due to withdrawal of consent, are\n             lost to follow-up or are serious protocol violators"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients who participated in the U Act Early study (ML22497)"
            }
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01918267", 
            "org_study_id": "ML28388"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 5, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Alkmaar", 
                        "country": "Netherlands", 
                        "zip": "1815 JD"
                    }
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amersfoort", 
                        "country": "Netherlands", 
                        "zip": "3818 ES"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Apeldoorn", 
                        "country": "Netherlands", 
                        "zip": "7334 DZ"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Breda", 
                        "country": "Netherlands", 
                        "zip": "4818 CK"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gouda", 
                        "country": "Netherlands", 
                        "zip": "2803 HH"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Groningen", 
                        "country": "Netherlands", 
                        "zip": "9700RB"
                    }
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Haarlem", 
                        "country": "Netherlands", 
                        "zip": "2035RC"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Heerlen", 
                        "country": "Netherlands", 
                        "zip": "6419 PC"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hilversum", 
                        "country": "Netherlands", 
                        "zip": "1213 HX"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hoofddorp", 
                        "country": "Netherlands", 
                        "zip": "2134 TM"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leeuwarden", 
                        "country": "Netherlands", 
                        "zip": "8934 AD"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leiden", 
                        "country": "Netherlands", 
                        "zip": "2333 ZA"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lelystad", 
                        "country": "Netherlands", 
                        "zip": "8233 AA"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nieuwegein", 
                        "country": "Netherlands", 
                        "zip": "3430 EM"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nijmegen", 
                        "country": "Netherlands", 
                        "zip": "6522 JV"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sneek", 
                        "country": "Netherlands", 
                        "zip": "8601 ZK"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Utrecht", 
                        "country": "Netherlands", 
                        "zip": "3584 GA"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Woerden", 
                        "country": "Netherlands", 
                        "zip": "3447 GN"
                    }
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Netherlands"
        }, 
        "number_of_groups": "1", 
        "overall_contact": {
            "email": "global.rochegenentechtrials@roche.com", 
            "last_name": "Reference Study ID Number: ML28388 www.roche.com/about_roche/roche_worldwide.htm", 
            "phone": "888-662-6728 (U.S. Only)"
        }, 
        "overall_official": {
            "affiliation": "Hoffmann-La Roche", 
            "last_name": "Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Netherlands: Medical Ethics Review Committee (METC)"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change in Disease Activity Score (DAS28)", 
            "safety_issue": "No", 
            "time_frame": "from baseline to Month 36"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01918267"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change in disability, assessed by the Dutch consensus Health Assessment Questionnaire (HAQ)", 
                "safety_issue": "No", 
                "time_frame": "from baseline to Month 36"
            }, 
            {
                "measure": "Measure of progressive joint destruction (vdHSS)", 
                "safety_issue": "No", 
                "time_frame": "from baseline of U-Act-Early to Month 24 of U-Act-After"
            }, 
            {
                "measure": "Changes in concomitant medication (especially tapering of corticosteroids)", 
                "safety_issue": "No", 
                "time_frame": "from baseline to Months 36"
            }, 
            {
                "measure": "Sustained remission rates/drug-free remission rates", 
                "safety_issue": "No", 
                "time_frame": "36 months"
            }, 
            {
                "measure": "Dose modifications/interruptions of RA treatment", 
                "safety_issue": "No", 
                "time_frame": "36 months"
            }, 
            {
                "measure": "Safety: Incidence of adverse events, adverse events of special interest and serious adverse events", 
                "safety_issue": "No", 
                "time_frame": "36 months"
            }
        ], 
        "source": "Hoffmann-La Roche", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hoffmann-La Roche", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}